wrong currency

Chapter 166 Observation Period

This artificial intelligence heart transplant operation took a total of eight hours of operation.

When they saw the stable operation of the artificial intelligence heart, the smooth continuation of the patient's vital signs, and various work indicators basically met expectations, the two brothers and sisters showed gratified smiles on their faces.

In the next month, the aspect that needs to be paid close attention to is the change of the patient's body temperature. An increase means inflammation, and a decrease may lead to the inability to continue life.

As for exclusion, it is basically non-existent.

The biggest feature of the artificial intelligence heart is that it does not need to be matched with the patient's heart.Because there is no blood type, there is no matching.

This is the same as the bypass devices implanted in various parts of the heart.

Have you ever heard of a case where the human body rejects implanted organs?
At present, the success rate of human heart transplantation in the entire medical field is 95%, the one-year survival rate after heart transplantation is 1%-85%, and the annual mortality rate is about 90%.

50%-80% of patients will have at least one rejection reaction, and most patients have no obvious manifestations, but 5% of patients will experience left ventricular dysfunction or atrial arrhythmia.

The peak period of rejection after heart transplantation is about 1 month, gradually decreases in the following 5 months, and tends to be stable at about 1 year.

One year after heart transplantation, most patients can reach grade I cardiac function, and more than 1% of patients can return to full-time work.

Patients who survive >1 year after heart transplantation have a good functional recovery, but exercise levels remain below normal, and cardiac function may gradually improve over time and with recovery of sympathetic function.

Heart transplantation is usually used for patients suffering from end-stage heart failure, coronary heart disease, arrhythmia, hypertrophic cardiomyopathy, congenital heart disease, etc., which are at risk of death and cannot be controlled by drugs.

For predictors of 1-year mortality, pretransplant included preoperative ventilatory dysfunction or left ventricular assist device, cachexia, female recipient or provider, and diagnoses other than heart failure or coronary artery disease, and posttransplant included reactive protein and Increased troponin levels.

The common main cause of death within 1 year was acute rejection or infection, and the main cause of death after 1 year was coronary vascular disease or lymphocyte hyperplasia after heart transplantation.

In view of this, the obstacles in the early stage of human heart transplantation are rejection and infection, and the obstacles in the later stage are coronary vascular disease and lymphocyte proliferation.

But the above-mentioned problems only occur in matched heart transplants.The artificial intelligence heart just avoids the above problems.

Therefore, the only thing to pay attention to in this operation is the infection problem, and the most obvious response to infection is the change of body temperature.

Brothers Ou Zhou and Jiang Yang took this as the first key point to monitor, and other aspects were monitored by vital signs.

As for the electrocardiogram, it is only useful when doing extracorporeal blood circulation, but it is useless in front of the artificial intelligence heart.

The operating status of the artificial intelligence heart will be monitored by vital signs instruments during hospitalization, and will be monitored and controlled by an intelligent control watch worn on the wrist after discharge.

This work was handed over to the three cardiac surgeons who participated in the operation as the first priority and focused on monitoring.

Ou Zhou and Jiang Yang only routinely checked once every morning.

Obviously, as long as the body temperature is normal and the vital sign instrument does not alarm, everything is OK.

On this day, Ou Zhou, Jiang Yang, and Ke Feier discussed with Jin Cheng and Liao Yunhui in the conference hall about the entrusted manufacturing of the artificial intelligence heart.

"Mr. Ou, we have contacted all the medical device manufacturing companies on the island. They seem to have doubts about the production prospects of the artificial intelligence heart as if they have been negotiated. How to deal with it?"

"If it doesn't work, let's look at the overseas countries. If it doesn't work, we can buy a company of this kind in Bay Island, and we will manage the processing and production of the artificial intelligence heart by ourselves." Ou Zhou said.

Jiang Yang continued: "I prefer to purchase nearby on the island, which is easy to manage, and can also develop the production of other product businesses without delaying the production of artificial intelligence hearts."

Ke Feier also said: "That's right, it's better to take the initiative than to be controlled by others."

Ou Zhou looked at Jin Cheng and Liao Yunhui and asked, "Which topic do you two prefer?"

The two rudder owners said almost in unison: "It would be ideal to purchase nearby."

"Okay, since everyone agrees to buy nearby, then we will adopt this plan. In addition, I have another idea, the target of the acquisition should preferably involve the production of cardiovascular and cerebrovascular medicines, so that it will be convenient for us to carry out in the future, supporting artificial intelligence heart The second phase of research and development of drugs to eliminate evil and promote good." Ou Zhou said.

"There are three companies on the island that develop cardiovascular and cerebrovascular drugs and produce medical devices, namely Jiahe Medical, Guirong Medical, and Shenshuan Biotech." Jin Cheng said like a few treasures.

Ou Zhou nodded and said with a smile, "Among the three companies, which one do you prefer to acquire?"

"Jiahe Medical." Jin Cheng said concisely.

"Tell me your reason?"

"Compared to those two companies, Jiahe Medical has three major products of its own, namely epinephrine preparations, ginseng injection, and cardiac defibrillator. The company's scale is also relatively moderate."

"Is this a listed company?" Ou Zhou asked enthusiastically.

"It's a listed company."

"You open this company's stock on the computer, let me take a look?" Ou Zhou ordered.

Jin Cheng came over and opened the stock market quotes of Bay Island on the computer in front of Ou Zhou, and searched for which company.

Ou Zhou saw that Jiahe Medical has a total share capital of 70 million, fully circulated, and a stock price of 23 NTD.

The main business is the development and production of cardiovascular and cerebrovascular drugs, and the development and production of medical equipment.

Listing date, July [-].

He focused on the shareholdings of the three major shareholders. The first largest shareholder held 20.00% of the shares, the second largest shareholder held 12.00%, and the third largest shareholder held [-]%.The rest are tradable shares.

Ou Zhou paid attention in his heart, and said with a smile, "Two helmsmen, do you have any securities accounts?"

Jin Cheng and Liao Yunhui looked at each other and said in unison: "Yes."

"It's easy to handle," Ou Zhou said with a fist and a smile, "Hmph, if you don't want to do business with the door-to-door, you must force us to use some means." He looked at Jin Cheng and Liao Yunhui. Several securities accounts, each account has no less than NT$50.00 million in funds. Then create some bad news for this company, causing its stock price to plummet, and you secretly buy it. This company has 8% of the market share. That is to say, there are still 30.00 million outstanding shares. When we buy 20.00% of the total share capital, we surpass the [-]% of the largest shareholder, and we can control it.”

Jin Cheng and Liao Yunhui said happily: "It's unexpected that Mr. Ou knows so much about the capital market at such a young age. It's really admirable."

"Haha, these are all plots in TV dramas, I just use them to practice. Who told them not to drink a toast, and to drink fine wine?" Ou Zhou laughed.

"However, there is a problem. This matter can only be done in secret. Once the major shareholders find out, they will cooperate with the other two shareholders to release good news to hedge the stock price, and may even compete with us for bargaining chips, causing the stock price to rise. Once such a situation occurs The situation is likely to disrupt our acquisition plan."

"Two helmsmen, we have two purposes for this move. First, it is better to be able to control the company smoothly. Second, in case the major shareholders are aware of the situation you mentioned, as long as we hold the With a large amount of shares in the company, we have a bargaining chip to negotiate terms with them. At that time, they can just agree. If they don’t agree, we will continue to create episodes for him. Hehe, let him fight the fire today and fill the hole tomorrow. It's fun."

Jin Cheng and Liao Yunhui laughed loudly, and said, "Mr. Ou, your style of play is a bit of a rogue. But it is very practical, so we will do it this way."

"The capital market is originally a battlefield without gunpowder. In order to benefit the common people, some extraordinary means must be used." Ou Zhou laughed.

Jiang Yang gave Jin Cheng a bank card and said with a smile: "There are 21 billion Hong Kong dollars in it, you can convert it into 10 billion NT dollars, and then we will start our acquisition plan."

Jin Cheng took the bank card and said with a smile: "If you have money, you are a master. Since Jiahe Medical is in our favor, then it is our dish."

After the two helmsmen left, Ke Feier smiled and said: "Like a father, like a son, Ou's father has been mastering the stock market for many years, and he has never used such a trick. When it comes to you, he has no teacher to do such a thing." out."

"Sister, the so-called big things don't stick to small things. We have no choice but to do this. Who made them ignorant of the big picture?"

Jiang Yang said with a smile: "Yes, we can be regarded as the first and then the soldiers. If they readily agree to the artificial intelligence heart production, why should we play this?"

"People say that the rivers and lakes are dangerous, but in my opinion, wherever there are benefits, there are dangers." Ke Feier said.

"Sister, we didn't do this for ourselves, so it's not insidious or cunning. If we look at it from another angle, after time, after Jiahe Medical grows under our hands, the three shareholders will make a lot of money. Thank you for being too late!"

"Looking at it this way, we are actually forcing them to make money, rather than seizing their assets." Jiang Yang laughed.

"So, as far as this matter is concerned, we should feel at ease, not feel ashamed." Ou Zhou laughed.

Ke Feier nodded, and said with a smile: "If you understand it this way, isn't it a good thing?"

"Since our three brothers and sisters have agreed, let's go and see the first artificial intelligence heart transplant patient who has contributed to the great cause of mankind?" Ou Zhou suggested.

The three of them left the hall and went to the intensive care unit of the Artificial Intelligence Heart Medical Research Institute.

The doctor on duty saw them come in, got up and reported the patient's performance.

The patient is not yet awake, but breathing steadily.

Ou Zhou personally took the patient's temperature and observed the vital signs.Various indicators show that everything is off to a good start.

Jiang Yang also repeated those actions.

Ou Zhou looked at the doctor on duty and said: "What this patient bears is not only our years of painstaking efforts, but also the gospel of all mankind. From the moment he received the artificial intelligence heart transplant, all his reactions And performance, will be recorded in the annals of human history!"

The doctor is from the Cardiovascular and Cerebrovascular Department of the Affiliated Hospital of Bay Island University. He is a well-known expert on the island. His name is Zeng Yiming. He is just over forty. He nodded and said, "I understand what Mr. Do your best to do every record and patient monitoring work."

Ou Zhou nodded: "Let us join hands to complete this great cause of human beings to eradicate evil and promote good!"

"Let us join hands to complete the great cause of human beings to eradicate evil and promote good."

This sentence has become the lifelong goal of the Artificial Intelligence Heart Transplantation Practice Institute.

(End of this chapter)